NEW YORK (GenomeWeb) – A quantitative nucleic acid amplification test for HIV-1 from Hologic has been granted pre-market approval from the US Food and Drug Administration, the company announced today.

The Aptima HIV-1 Quant test runs on Hologic's fully automated Panther system and amplifies RNA from patient plasma specimens for the purposes of HIV viral load monitoring in the US. Outside the US, it is CE-IVD marked for both diagnosis and monitoring.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Aug
20
Sponsored by
Canon BioMedical

This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.